BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

680 related articles for article (PubMed ID: 22932115)

  • 1. Concurrent acute cellular rejection is an independent risk factor for renal allograft failure in patients with C4d-positive antibody-mediated rejection.
    Matignon M; Muthukumar T; Seshan SV; Suthanthiran M; Hartono C
    Transplantation; 2012 Sep; 94(6):603-11. PubMed ID: 22932115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of C4d staining as a humoral injury marker.
    Kara M; Demir F; Ata P; Ozel L; Gumrukcu G; Unal E; Canbakan M; Gucun M; Esadoglu V; Ozdemir E; Cemel H; Titiz MI
    Transplant Proc; 2012; 44(6):1694-6. PubMed ID: 22841245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Capillary C4d and Kidney Allograft Outcome in Relation to Morphologic Lesions Suggestive of Antibody-Mediated Rejection.
    Kikić Ž; Kainz A; Kozakowski N; Oberbauer R; Regele H; Bond G; Böhmig GA
    Clin J Am Soc Nephrol; 2015 Aug; 10(8):1435-43. PubMed ID: 26071493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Banff Component Scoring-based Histologic Assessment of Bortezomib-based Antibody-mediated Rejection Therapy.
    Sadaka B; Ejaz NS; Shields AR; Cardi MA; Wadih G; Witte D; Abu Jawdeh BG; Alloway RR; Woodle ES
    Transplantation; 2015 Aug; 99(8):1691-9. PubMed ID: 25803498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute cellular rejection: impact of donor-specific antibodies and C4d.
    Willicombe M; Roufosse C; Brookes P; McLean AG; Galliford J; Cairns T; Cook TH; Taube D
    Transplantation; 2014 Feb; 97(4):433-9. PubMed ID: 24430742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of Complement-binding Donor-specific Antibodies, Not IgG-antibody Strength Nor C4d Status, at Antibody-mediated Rejection Diagnosis Is an Independent Predictor of Kidney Graft Failure.
    Malheiro J; Santos S; Tafulo S; Dias L; Martins S; Fonseca I; Almeida M; Pedroso S; Beirão I; Castro-Henriques A; Cabrita A
    Transplantation; 2018 Nov; 102(11):1943-1954. PubMed ID: 29757900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C4d deposits in acute "cell-mediated" rejection: a marker for renal prognosis?
    Neves M; Cotovio P; Machado S; Santos L; Macário F; Alves R; Pratas J; Xavier da Cunha M; Mota A; Campos M
    Transplant Proc; 2012 Oct; 44(8):2360-5. PubMed ID: 23026593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term kidney allograft survival in patients with transplant glomerulitis.
    Nabokow A; Dobronravov VA; Khrabrova M; Gröne HJ; Gröne E; Hallensleben M; Kieneke D; Weithofer P; Smirnov AV; Kliem V
    Transplantation; 2015 Feb; 99(2):331-9. PubMed ID: 25594551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rejection of the Renal Allograft in the Absence of Demonstrable Antibody and Complement.
    Zhao X; Huang G; Randhawa S; Zeng G; Lunz J; Randhawa P
    Transplantation; 2017 Feb; 101(2):395-401. PubMed ID: 26901079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression patterns of B cells in acute kidney transplant rejection.
    Carpio VN; Noronha Ide L; Martins HL; Jobim LF; Gil BC; Külzer AS; Loreto Mda S; Gonçalves LF; Manfro RC; Veronese FV
    Exp Clin Transplant; 2014 Oct; 12(5):405-14. PubMed ID: 25299368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of late antibody-mediated rejection (C4d-mediated rejection): a single-center experience.
    Tatar E; Uslu A; Simsek C; Vardar E
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():259-62. PubMed ID: 25894167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma C4d+ Endothelial Microvesicles Increase in Acute Antibody-Mediated Rejection.
    Tower CM; Reyes M; Nelson K; Leca N; Kieran N; Muczynski K; Jefferson JA; Blosser C; Kukla A; Maurer D; Chandler W; Najafian B
    Transplantation; 2017 Sep; 101(9):2235-2243. PubMed ID: 27846156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal allograft C4d deposition in Chinese: Hong Kong perspective.
    Yuen SK; Mak YF; Tang HL; Yong SP; Chow KM; Chu KH; Fung KS; Chan WH; Tong KL
    Nephrology (Carlton); 2008 Jun; 13(3):256-63. PubMed ID: 18315707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bortezomib in late antibody-mediated kidney transplant rejection (BORTEJECT Study): study protocol for a randomized controlled trial.
    Eskandary F; Bond G; Schwaiger E; Kikic Z; Winzer C; Wahrmann M; Marinova L; Haslacher H; Regele H; Oberbauer R; Böhmig GA
    Trials; 2014 Apr; 15():107. PubMed ID: 24708575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The importance of C4d in biopsies of kidney transplant recipients.
    Corrêa RR; Machado JR; da Silva MV; Helmo FR; Guimarães CS; Rocha LP; Faleiros AC; dos Reis MA
    Clin Dev Immunol; 2013; 2013():678180. PubMed ID: 23935649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subclinical Rejection Phenotypes at 1 Year Post-Transplant and Outcome of Kidney Allografts.
    Loupy A; Vernerey D; Tinel C; Aubert O; Duong van Huyen JP; Rabant M; Verine J; Nochy D; Empana JP; Martinez F; Glotz D; Jouven X; Legendre C; Lefaucheur C
    J Am Soc Nephrol; 2015 Jul; 26(7):1721-31. PubMed ID: 25556173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C4d deposition in allograft renal biopsies is an independent risk factor for graft failure.
    Wang R; Wang H; Chen J; Wu J; Wang Y; Huang H; He Q
    Nephrology (Carlton); 2009 Aug; 14(5):527-32. PubMed ID: 19674321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C4d-negative antibody-mediated rejection in renal allografts: evidence for its existence and effect on graft survival.
    Haas M
    Clin Nephrol; 2011 Apr; 75(4):271-8. PubMed ID: 21426880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased C4d in post-reperfusion biopsies and increased donor specific antibodies at one-week post transplant are risk factors for acute rejection in mild to moderately sensitized kidney transplant recipients.
    Djamali A; Muth BL; Ellis TM; Mohamed M; Fernandez LA; Miller KM; Bellingham JM; Odorico JS; Mezrich JD; Pirsch JD; D'Alessandro TM; Vidyasagar V; Hofmann RM; Torrealba JR; Kaufman DB; Foley DP
    Kidney Int; 2013 Jun; 83(6):1185-92. PubMed ID: 23447068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of complement split product C4d in ABO-compatible liver allograft: diagnosing utility in acute antibody mediated rejection.
    Ali S; Ormsby A; Shah V; Segovia MC; Kantz KL; Skorupski S; Eisenbrey AB; Mahan M; Huang MA
    Transpl Immunol; 2012 Jan; 26(1):62-9. PubMed ID: 21907804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.